Most Recent
A lawyer for Rentokil has told a court the pest control company is scratching its head over the defence by a former manager accused of a $3.2 million fraudulent invoice scheme, noting the employee admits invoices were paid into his personal account.
Generic drug maker Sandoz AG has filed proceedings seeking the revocation of two patents registered in Australia by German pharmaceutical giant Bayer covering its top-selling blood clot drug Xarelto.
A judge overseeing a climate change class action against the government will be invited to visit the Torres Strait to see the alleged erosion of sacred sites, but before then the Commonwealth is seeking details on when it allegedly knew of the effects of global warming and the scope of its alleged duty of care.
Construction equipment giant Caterpillar has resolved its dispute with a former employee accused of flagrantly copying "many thousands" of confidential files before taking a job with a competitor.
Melbourne-based joint venture Shepparton Partners Collective has lost its appeal of a $1.2 million judgment that found it infringed software developer QAD's copyright by failing to pay a transfer fee to retain the licence after it acquired the iconic SPC Ardmona cannery in Victoria from Coca-Cola Amatil for $40 million.
A court has summarily dismissed a lawsuit accusing the Victorian government of acting unlawfully by improving the Western Highway and threatening to harm six 'directions' trees of cultural significance to the Djab Wurrung people.
Law firm Sparke Helmore acted negligently by failing to adequately advise a New South Wales property developer about extension of time notices that were needed to prevent two lucrative contracts from falling through, a judge has found.
A class action on behalf of people who claim they developed non-Hodgkin lymphoma after using Monsanto's Roundup weed killer will argue the agrochemical giant should be hit with exemplary damages for its negligence in selling the herbicide, which the company allegedly knew caused cancer.
ASIC has won its bid to wind up accused Sydney fraudster Melissa Caddick's company and appoint final receivers to realise her assets, paving the way for some repayment to the dozens of family and friends who invested with Caddick and are still owed $23.5 million.
Bristol-Myers Squib unit Celgene Corporation has sued Indian generics giant Dr Reddy’s Laboratories for allegedly threatening to infringe eight patents for its blockbuster cancer drug Revlimid, which raked in US$12 billion for the US-based company in revenue last year.